A corporate PAC, or Political Action Committee, is a fund set up by a corporation to collect money from its executives and employees and donate it to political candidates. Federal law prohibits corporations from donating directly to campaigns from their general treasury. PACs get around that restriction by pooling voluntary contributions from people associated with the company and funneling that money into elections. The result is the same: corporations influence who gets elected and what policies they support once in office.

PACs are legal. They're registered with the Federal Election Commission, they file public reports, and they operate under rules that have been in place for decades. That's part of what makes them effective. The influence they buy is public record. It's just accepted as how politics works.

How a Corporate PAC Actually Works

A company sets up a PAC and asks its executives, managers, and sometimes broader employees to contribute. Federal law caps individual contributions to a PAC at $5,000 per year. The PAC then distributes that money to candidates, subject to its own contribution limits of $5,000 per candidate per election.

The companies running the most active PACs are concentrated in industries with the most at stake in federal legislation: pharmaceuticals, finance, real estate, defense, oil and gas, and telecommunications. These are industries where a single regulatory decision or piece of legislation can shift billions of dollars in profits. Spending a few million dollars on PAC contributions to influence those decisions is, from a pure return-on-investment standpoint, one of the most profitable things a corporation can do.

PAC contributions come with an understood expectation of access. A senator who has received $50,000 in PAC contributions from pharmaceutical companies over their career returns the pharmaceutical lobby's calls, takes the meetings, and hears concerns before legislation is drafted. When it comes time to vote on measures that would cost the industry money, the senator thinks carefully. The PAC money buys access, not guaranteed outcomes. It buys the relationship that shapes outcomes over time.

Super PACs Are a Different Animal

Super PACs emerged from two Supreme Court decisions in 2010 and operate under different rules than traditional PACs. They can raise and spend unlimited amounts of money from corporations, unions, and wealthy individuals. The one restriction is that they're legally prohibited from coordinating directly with the campaigns they support.

In practice, that restriction does less work than it sounds like it should. Super PACs are often run by former campaign staff, close allies of the candidate, or people with extensive personal relationships with the campaign. The ads they run, the voter contact they do, and the opposition research they deploy all benefit the candidate without the campaign being technically responsible for any of it.

The amounts involved are dramatically larger than traditional PAC money. In the 2024 election cycle, Super PACs spent billions of dollars on federal races. A single wealthy donor or a single corporation can write a check for millions of dollars to a Super PAC supporting a candidate they want elected. That scale of financial support creates obligations that $5,000 contributions do not.

What This Looks Like in Practice

The pharmaceutical industry's PAC and lobbying activity is among the most documented in federal politics. The industry has consistently spent to protect its pricing power, block Medicare drug price negotiation, and limit regulations on drug advertising and patent protections. For decades those efforts worked: Medicare was legally prohibited from negotiating drug prices, a restriction that existed in no other comparable country.

The financial industry's PAC spending has shaped banking regulation across multiple administrations and congressional sessions. Provisions of financial reform legislation that would have directly constrained bank profits were weakened, delayed, or stripped out entirely in legislative processes where industry PAC money was flowing heavily to the relevant committee members.

The real estate industry uses PAC contributions at the state and federal level to oppose zoning reform, tenant protections, and affordable housing mandates that would affect property values and development profits. The same communities struggling with unaffordable rent are often represented by politicians who have received substantial real estate PAC money.

The Disclosure Problem

PAC contributions are publicly disclosed, which sounds like accountability but functions more like a map of who owns whom. The disclosures are real, but the system that produces them is considered legitimate, which means the influence being disclosed is considered acceptable. A politician can receive hundreds of thousands of dollars from pharmaceutical PACs over a career, vote consistently against drug price reform, and face no legal consequence because none of it is illegal.

Dark money, which flows through nonprofit organizations that don't have to disclose their donors, adds another layer of influence that doesn't even appear in the public record. The disclosed PAC money is the visible portion of a larger system of corporate political spending.

Why the Labor Party Takes None of It

The Labor Party does not accept contributions from corporate PACs, Super PACs, or political organizations funded by corporations. Its candidates are funded by individual members. It's a choice about what kind of party this is going to be. A candidate who has taken pharmaceutical PAC money owes the pharmaceutical industry something. A candidate who hasn't, doesn't. The policy outcomes that follow from those two situations are different, and those differences show up in your drug prices, your rent, and your paycheck.

PACs are legal. They're disclosed. They're accepted. And they're the mechanism by which corporations convert money into policy outcomes at your expense. Refusing to participate in that system is the only way to actually be free of it.